Ghaf Capital Partners — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Bluewhalebluewhale.bioinMar 2024 · $7M
BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)in
BoardPaul Meister(Director)Elaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Co-investorsAscendo VenturesNovalis LifeSciencesBaselayer CapitalCardanogumi IncPRIMAL CAPITAL+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.